Healthcare provider profile · identity verified

Lynn Beatty Athens, MD

Family Practice · LINCOLN CITY, OR · NPI 1164522785

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	286	58
Quetiapine Fumarate	Quetiapine Fumarate	271	43
Atorvastatin Calcium	Atorvastatin Calcium	268	55
Amlodipine Besylate	Amlodipine Besylate	244	44
Trazodone Hcl	Trazodone Hcl	224	44
Sertraline Hcl	Sertraline Hcl	189	31
Omeprazole	Omeprazole	168	32
Potassium Chloride	Potassium Chloride	165	32
Furosemide	Furosemide	164	39
Lisinopril	Lisinopril	152	36
Metoprolol Succinate	Metoprolol Succinate	137	26
Metoprolol Tartrate	Metoprolol Tartrate	121	21
Gabapentin	Gabapentin	115	23
Eliquis	Apixaban	114	27
Losartan Potassium	Losartan Potassium	111	22
Pantoprazole Sodium	Pantoprazole Sodium	108	19
Famotidine	Famotidine	104	20
Buspirone Hcl	Buspirone Hcl	94	18
Tamsulosin Hcl	Tamsulosin Hcl	93	14
Risperidone	Risperidone	86	suppressed
Donepezil Hcl	Donepezil Hcl	80	13
Clopidogrel	Clopidogrel Bisulfate	76	13
Oxycodone Hcl	Oxycodone Hcl	74	21
Citalopram Hbr	Citalopram Hydrobromide	67	13
Metformin Hcl	Metformin Hcl	64	14
Hydrochlorothiazide	Hydrochlorothiazide	63	14
Memantine Hcl	Memantine Hcl	60	suppressed
Lovastatin	Lovastatin	58	suppressed
Simvastatin	Simvastatin	57	suppressed
Fluticasone Propionate	Fluticasone Propionate	56	21
Hydroxyzine Hcl	Hydroxyzine Hcl	54	suppressed
Olanzapine	Olanzapine	51	suppressed
Allopurinol	Allopurinol	49	suppressed
Duloxetine Hcl	Duloxetine Hcl	49	suppressed
Spironolactone	Spironolactone	47	suppressed
Lorazepam	Lorazepam	46	16
Escitalopram Oxalate	Escitalopram Oxalate	45	suppressed
Levetiracetam	Levetiracetam	45	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	44	suppressed
Diclofenac Sodium	Diclofenac Sodium	44	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	44	13
Lactulose	Lactulose	42	suppressed
Midodrine Hcl	Midodrine Hcl	40	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	40	12
Divalproex Sodium	Divalproex Sodium	38	suppressed
Finasteride	Finasteride	37	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	30
Cephalexin	Cephalexin	33	29
Mirtazapine	Mirtazapine	33	suppressed
Montelukast Sodium	Montelukast Sodium	33	11
Alcohol Prep Pads	Alcohol Antiseptic Pads	32	suppressed
Xarelto	Rivaroxaban	32	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	28	18
Alendronate Sodium	Alendronate Sodium	28	suppressed
Carvedilol	Carvedilol	28	suppressed
Lamotrigine	Lamotrigine	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Aripiprazole	Aripiprazole	26	suppressed
Nystatin	Nystatin	26	16
Constulose	Lactulose	25	suppressed
Azithromycin	Azithromycin	24	19
Januvia	Sitagliptin Phosphate	24	suppressed
Clonazepam	Clonazepam	23	suppressed
Methylprednisolone	Methylprednisolone	23	18
Baclofen	Baclofen	22	suppressed
Loperamide	Loperamide Hcl	22	12
Ondansetron Odt	Ondansetron	22	suppressed
Prednisone	Prednisone	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Meloxicam	Meloxicam	18	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	18	suppressed
Naproxen	Naproxen	18	suppressed
Primidone	Primidone	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	15
Bumetanide	Bumetanide	17	suppressed
Divalproex Sodium Er	Divalproex Sodium	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Lurasidone Hcl	Lurasidone Hcl	16	suppressed
Tramadol Hcl	Tramadol Hcl	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Nortrel	Norethindrone-Ethin. Estradiol	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Tobramycin	Tobramycin	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Ammonium Lactate	Ammonium Lactate	14	suppressed
Atenolol	Atenolol	14	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Comfort Ez Pro Safety Pen Ndl	Pen Needle, Diabetic, Safety	14	suppressed
Digoxin	Digoxin	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Phenytoin	Phenytoin	14	suppressed
Topiramate	Topiramate	14	suppressed
Clindamycin Hcl	Clindamycin Hcl	13	12
Glipizide	Glipizide	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Lithium Carbonate	Lithium Carbonate	13	suppressed
Ramelteon	Ramelteon	13	suppressed
Tiotropium Bromide	Tiotropium Bromide	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Vilazodone Hcl	Vilazodone Hcl	13	suppressed
Zonisamide	Zonisamide	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Rivastigmine	Rivastigmine	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Sulfasalazine	Sulfasalazine	12	suppressed
Calcitriol	Calcitriol	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Olanzapine Odt	Olanzapine	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error